Vaccines approved! SII, Bharat Biotech get DCGI nod for restricted use in emergency situation
SII Pune has submitted safety immunogenicity and efficacy data generated on 23,745 participants, The overall vaccine efficacy was found to be 70.42 per cent.
Share Via Email
| A+A A-
DGCI has accepted the govt panel s recommendation to grant restricted emergency use authorization to Covishield, Covaxin.
Express News Service
NEW DELHI: V G Somani, Drug Controller General of India (DCGI) on Sunday announced that the recommendations of a government-appointed panel to grant restricted emergency use authorization to Covid-19 vaccines by Serum Institute of India and Bharat Biotech in the country are being accepted.
India News: Senior Congress leader Shashi Tharoor on Sunday said that the emergency approval to COVID-19 vaccine Covaxin is premature and could be dangerous as i
India News: As India gears up for the world's largest vaccination programme, the Drugs Controller General of India (DCGI) on Sunday quelled rumours surrounding th